The global Biosurgery market was valued at $11,425.5 million in 2020, and is projected to reach $27,324.8 million by 2030, registering a CAGR of 9.1% from 2021 to 2030.
Biosurgery products consist of synthetic, semisynthetic or natural material that help in tissue repair and seal surgical incision. Biosurgery products are used in various surgeries to minimize the intra and post-operative complications. Biosurgery products also help facilitate tissue sealing hemostasis. Moreover, biosurgery products are used in hard tissue regeneration in ortho-biologics. Various synthetic and biologic products, such as anti-adhesive agents, hemostatic agents, surgical sealing agents, bone graft substitutes, and soft tissue management are utilized in surgeries for prevention of excessive blood loss or providing adhesion or wound/tissue sealing.
The growth of the global biosurgery market is majorly driven by increase in prevalence of chronic disease, trauma, rise in government and private organizations initiatives for development of the medical devices sector, surge in number of surgical procedures, and rise in demand for biosurgery products.
Furthermore, rise in number of geriatric population drives the growth of the market. This is attributed to the fact that geriatric population is highly vulnerable to chronic diseases, which boosts the need for various surgical procedure and upsurge the demand for biosurgery products. This factor is expected to notably contribute toward the growth of the global biosurgery market.
In addition, increase in sports-related injuries and surgeries, increase in sedentary lifestyle, and rise in several approvals for biosurgery, drive the growth of the global biosurgery market.
In addition, increase in R&D activities in the healthcare industry and rise in blood loss management systems are anticipated to provide lucrative opportunities for the market expansion.
However, high cost of biosurgery products and stringent government regulations hinder the market growth. On the contrary, increase in awareness among physicians and researchers about the use of biosurgery products augments the growth of the biosurgery market. This has further encouraged many key players to enter emerging markets, thus offering lucrative opportunities for the expansion of the biosurgery market.
The biosurgery market is segmented on the basis of product type, application, source, and region. Depending on the product type, the market is divided into anti-adhesive agents, hemostatic agents and surgical sealants, bone graft substitutes, and mesh (soft tissue management). On the basis of application, the market is segmented into cardiovascular and thoracic, neuro and spine surgery, orthopedic surgery, and general surgery. On the basis of source, the market is segmented into biologics products, and synthetic products. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global biosurgery market are Aroa Biosurgery Limited, B. Braun Melsungen AG, Baxter International Inc., BD (Becton, Dickinson and Company), Hemostasis LLC, Integra LifeSciences Holdings Corp., Johnson and Johnson, Medtronic PLC, Sanofi S.A., Tissue Regenix Groups.
Biosurgery products consist of synthetic, semisynthetic or natural material that help in tissue repair and seal surgical incision. Biosurgery products are used in various surgeries to minimize the intra and post-operative complications. Biosurgery products also help facilitate tissue sealing hemostasis. Moreover, biosurgery products are used in hard tissue regeneration in ortho-biologics. Various synthetic and biologic products, such as anti-adhesive agents, hemostatic agents, surgical sealing agents, bone graft substitutes, and soft tissue management are utilized in surgeries for prevention of excessive blood loss or providing adhesion or wound/tissue sealing.
The growth of the global biosurgery market is majorly driven by increase in prevalence of chronic disease, trauma, rise in government and private organizations initiatives for development of the medical devices sector, surge in number of surgical procedures, and rise in demand for biosurgery products.
Furthermore, rise in number of geriatric population drives the growth of the market. This is attributed to the fact that geriatric population is highly vulnerable to chronic diseases, which boosts the need for various surgical procedure and upsurge the demand for biosurgery products. This factor is expected to notably contribute toward the growth of the global biosurgery market.
In addition, increase in sports-related injuries and surgeries, increase in sedentary lifestyle, and rise in several approvals for biosurgery, drive the growth of the global biosurgery market.
In addition, increase in R&D activities in the healthcare industry and rise in blood loss management systems are anticipated to provide lucrative opportunities for the market expansion.
However, high cost of biosurgery products and stringent government regulations hinder the market growth. On the contrary, increase in awareness among physicians and researchers about the use of biosurgery products augments the growth of the biosurgery market. This has further encouraged many key players to enter emerging markets, thus offering lucrative opportunities for the expansion of the biosurgery market.
The biosurgery market is segmented on the basis of product type, application, source, and region. Depending on the product type, the market is divided into anti-adhesive agents, hemostatic agents and surgical sealants, bone graft substitutes, and mesh (soft tissue management). On the basis of application, the market is segmented into cardiovascular and thoracic, neuro and spine surgery, orthopedic surgery, and general surgery. On the basis of source, the market is segmented into biologics products, and synthetic products. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global biosurgery market are Aroa Biosurgery Limited, B. Braun Melsungen AG, Baxter International Inc., BD (Becton, Dickinson and Company), Hemostasis LLC, Integra LifeSciences Holdings Corp., Johnson and Johnson, Medtronic PLC, Sanofi S.A., Tissue Regenix Groups.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the biosurgery market analysis from 2020 to 2030 to identify the prevailing biosurgery market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the biosurgery market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global biosurgery market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
- Anti Adhesive Agents
- Bone Graft Substitutes
- Hemostatic And Surgical Sealant
- Mesh
By Application
- Cardiovascular And Thoracic Surgery
- Neuro And Spine Surgery
- Orthopedic Surgery
- General Surgery
By Source
- Biologics Products
- Synthetic Products
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Rest of Europe
- Asia-Pacific
- China
- Japan
- Australia
- India
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- aroa biosurgery limited
- Baxter International Inc.
- B. BRAUN MELSUNGEN AG
- Becton, Dickinson and Company
- HEMOSTASIS LLC
- INTEGRA LIFE SCIENCES HOLDINGS CORP
- JOHNSON and JOHNSON SERVICES, INC.
- Medtronic, Inc.
- SANOFI S A
- TISSUE REGENIX GROUP
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: BIOSURGERY MARKET, BY PRODUCT TYPE
CHAPTER 5: BIOSURGERY MARKET, BY APPLICATION
CHAPTER 6: BIOSURGERY MARKET, BY SOURCE
CHAPTER 7: BIOSURGERY MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
Biosurgery is defined as a surgical technique, which is used to reduce intra- and post-operative complications by facilitating hemostasis and tissue sealing. It offers application in hard tissue regeneration in orthobiologics. Bio-surgery products contain primarily semi-synthetic, synthetic, or natural materials that help is sealing surgical incisions. They also control loss of blood for various surgical conditions, such as cardiovascular surgery, gynecology surgery, and orthopedic surgery.Factors that drive growth of the global biosurgery market size include, rise in demand for surgical procedure, advancements in the medical device industry, and surge in demand for biosurgery products. In addition, rise in prevalence of chronic diseases contributes toward the growth of the global biosurgery market. Market players focus on manufacturing of different biosurgery products to offer better outcome after surgical procedures. Moreover, increase in prevalence of geriatric population and surge in need for blood loss management system accelerate the biosurgery market growth.
Moreover, rise in disposable income and development of R&D activities for manufacturing advanced biosurgery products are anticipated to drive the growth of the biosurgery market share. Rise in sedentary lifestyle and increase in number of sports-related injuries and surgeries, surge the need for biosurgery products, and surge the demand for biosurgery industry. These are the key factors that boost growth of the biosurgery market size.
The biosurgery market is segmented on the basis of product type, application, source, and region. Depending on product, the market is divided into anti-adhesive agents, hemostatic agents, surgical sealants, bone graft substitutes, and mesh. The bone graft substitutes segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to surge in demand for bone graft substituent product and increase in number of sports injuries and surgeries. Depending on application, the market is divided into thoracic, neuro and spine surgery, orthopedic surgery, and general surgery. The neuro and spine surgery segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in prevalence of neurological disorder.
Depending on source, the market is divided into biologics products, and synthetic products. The biologics products segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in demand for natural products and rise in technological development in pharmaceutical sector.
The COVID-19 outbreak negatively impacted growth of the global biosurgery market. The COVID-19 pandemic stressed healthcare systems across the globe. The soft tissue orthopaedic and urogynecology procedure is profoundly affected by the COVID-19 pandemic. A number of clinics and hospitals were restructured to increase hospital capacities for patients diagnosed with COVID-19. Implementation of lockdown, owing to the COVID-19 outbreak resulted in decline in number of patient visits for other diseases, such as cancer and diabetes, during the pandemic. For instance, in 2021, Tissue Regenix Group, a medical technology company, reported that approximately 22% of biosurgery revenue decreased due to cancellation of elective surgical procedures.
According to Onkar Sumant, Manager, Healthcare, 'Alarming rise in prevalence of chronic diseases, advancements in the medical device sector, rise in demand for biosurgery products, and increase in number of sports-related surgery are expected to notably contribute toward the growth of the global biosurgery market analysis during the forecast period.'
KEY FINDINGS OF THE STUDY
- On the basis of product type, the bone graft substitutes segment was the highest contributor to the market in 2020, and is expected to continue this trend during the biosurgery market forecast period.
- On the basis of application, the neuro and spine surgery segment dominated the market in 2020, and is expected to continue this trend during the forecast period.
- On the basis of source, the biologics product segment dominated the market in 2020, and is expected to continue this trend during the forecast period.
- Region-wise, North America garnered the largest revenue share in 2020, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- aroa biosurgery limited
- Baxter International Inc.
- B. BRAUN MELSUNGEN AG
- Becton, Dickinson and Company
- HEMOSTASIS LLC
- INTEGRA LIFE SCIENCES HOLDINGS CORP
- JOHNSON and JOHNSON SERVICES, INC.
- Medtronic, Inc.
- SANOFI S A
- TISSUE REGENIX GROUP
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 180 |
| Published | March 2022 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 11425.5 million |
| Forecasted Market Value ( USD | $ 27324.8 million |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
